Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Targeted therapy for brain cancer shows efficacy

Written by | 10 Jun 2023

In patients diagnosed with grade 2 IDH-mutant glioma, treatment with investigative vorasidenib has significantly improved progression-free survival. The findings were published on June 5, 2023 in the NEJM/New… read more.

New drug delays progression of glioma, a deadly brain cancer

Written by | 7 Jun 2023

In an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend the amount of time people with a subtype of glioma… read more.

Keytruda + chemotherapy before surgery and continued as a single agent after surgery reduced the risk of event-free survival events by 42% versus pre-operative chemotherapy in resectable Stage II, IIIA or IIIB NSCLC – Merck Inc

Written by | 7 Jun 2023

Merck known as MSD outside of the United States and Canada, announced positive results from the pivotal Phase III KEYNOTE-671 trial evaluating Keytruda, Merck’s anti-PD-1 therapy, as a… read more.

Could pharmacist-prescribing reduce chemotherapy errors?

Written by | 24 May 2023

Shannon Nally is a pharmacist with a strong background in aseptic pharmacy work and oncology. Whilst studying for a master’s degree at University College Cork (UCC) she undertook… read more.

How investment could help reduce chemotherapy prescribing errors

Written by | 23 May 2023

Chemotherapy prescribing is an “error-prone process” according to Shannon Nally, the author of a study conducted at University Hospital, Limerick. The findings suggest that prescribing of chemotherapy by… read more.

Investigating chemotherapy prescribing errors

Written by | 22 May 2023

Shannon Nally is a pharmacist with a strong background in aseptic pharmacy work and oncology. Whilst studying for a master’s degree at University College Cork (UCC) she undertook… read more.

New ACR Breast Cancer Screening Guidelines call for earlier and more-intensive screening for high-risk women

Written by | 9 May 2023

New American College of Radiology® (ACR®) breast cancer screening guidelines now call for all women — particularly Black and Ashkenazi Jewish women — to have risk assessment by age 25 to determine… read more.

Community health van increases access to a vaccine that helps to prevent six types of cancer

Written by | 6 May 2023

In a joint initiative that includes Hollings Cancer Center and the Department of Pediatrics, MUSC researchers launched a community mobile health van in 2021 to help to increase… read more.

Severe mental illness linked to low attendance at cancer screening

Written by | 5 May 2023

People with severe mental illness are less likely to attend cancer screening compared to those who do not have such conditions, according to new research from the University… read more.

Medicinal cannabis can safely relieve cancer pain and curb total meds and opioid use

Written by | 4 May 2023

Medicinal cannabis can safely relieve cancer pain, while curbing the total number of meds and opioids taken, suggest the results of a multicentre registry study, published online in BMJ… read more.

A new method to test cancer drug toxicity

Written by | 3 May 2023

For people with cancer, chemotherapy saves lives, but for some patients, the treatment comes with a side effect—heart damage. Screening cancer drugs for cardiotoxicity has been an ongoing… read more.

Cannabis knocks down pain, improves sleep and lifts brain fog in cancer patients

Written by | 2 May 2023

Cancer patients who use cannabis to address their symptoms have less pain and sleep better, according to new University of Colorado Boulder research. But they also experience another,… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.